Skip to main content

2.

Relationship between serum proliferative activity (% of control serum value) (mean±S.D.) and clinicopathologic variables in patients with colorectal cancer

Patient number (n) Proliferation (%) Significance
Primary tumour location
 Colon 29 208 ± 47
 Rectum 24 220 ± 34 P= 0.276*
TNM stage
 T1/2N0M0 9 219 ± 46
 T3/4N0M0 26 209 ± 43
 T1/2N1M0 5 209 ± 34
 T3/4N1M0 3 228 ± 56
 T4NxM0 2 213 ± 20
 T4NxM1 8 217 ± 44 P= 0.971**
Histologic grade
 1 Poorly differentiated 17 223 ± 37
 2 Moderately differentiated 28 206 ± 47
 3 Well differentiated 5 211 ± 24 P= 0.404**
 Unknown 3
Tumour category
 pT1 1 252
 pT2 9 207 ± 49
 pT3 33 214 ± 36
 pT4 10 212 ± 54 P= 0.798**
Lymph node metastases
 Absent 36 214 ± 42
 Present 13 214 ± 40 P= 0.962*
 Unknown 4
Distant metastases
 Absent 45 212 ± 41
 Present 8 218 ± 44 P= 0.746*
*

Student's t-test.

*

*One-way ANOVA.